GlassScriptPhysician profile
Aaron Bradley Parrish
NPI 1366799868
$21,637.46
in general payments reported to CMS, 2019-2025
22 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $20.67 · 2021: $7,339 · 2022: $6,177 · 2023: $5,525 · 2024: $1,901 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,824 · Food and Beverage: $839 · Travel and Lodging: $46.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,823.87 |
| Food and Beverage | $839.11 |
| Travel and Lodging | $46.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $12,819.42 | 2022-2024 | |
| Intuitive Surgical, INC. | $7,337.78 | 2021-2022 | |
| Medtronic, INC. | $260.61 | 2023-2025 | Interstim |
| Braintree Laboratories, INC. | $260.18 | 2019-2024 | Sutab, Suflave |
| Acelrx Pharmaceuticals, INC. | $123.34 | 2019 | |
| Boston Scientific Corporation | $122.90 | 2019 | |
| Integra Lifesciences Corporation | $91.28 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $86.15 | 2023-2025 | Stravix, Grafix |
| Biotissue Holdings INC. | $82.62 | 2024 | |
| Aroa Biosurgery Incorporated | $70.10 | 2024 | |
| Baxter Healthcare | $56.06 | 2022-2023 | Tisseel |
| Heron Therapeutics, INC. | $51.52 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $45.84 | 2020-2022 | |
| Abbott Laboratories | $34.30 | 2021 | |
| Mimedx Group, INC. | $34.26 | 2024-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $34.08 | 2025 | |
| Springworks Therapeutics, INC. | $33.38 | 2024 | Ogsiveo |
| Coloplast Corp | $25.79 | 2024 | |
| Ethicon US, LLC | $19.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.47 | 2021 | |
| Trevena, INC. | $16.17 | 2023 | Olinvyk |
| Alfasigma USA, INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.